Your search for smoking cessation returned 306 results

The FDA determined the benefits of this smoking cessation therapy outweighed the potential risks.

Even patients quitting in their 60s can add years to their lives, researchers find

A recent survey found that a substantial number of clinicians believe e-cigarettes can help patients reduce or stop smoking, with 37.9% stating they having recommended e-cigarettes to patients who smoke.

According to a study in The American Journal of Drug and Alcohol Abuse, psilocybin showed promise in promoting long-term smoking abstinence in the context of a structured treatment program.

New trial data may alleviate some concerns regarding the smoking cessation medications varenline, bupropion and nicotine patches and the risk of neuropsych events.

Three years into the campaign, ads targeting smoking are still having a significant impact, according to the U.S. Centers for Disease Control and Prevention.

Stopping over time is less effective, British researchers say

Varenicline did not increase the rate of cardiovascular (CV) serious adverse events, according to data from a systematic review published in the Journal of the American Heart Association.

Researchers found no significant differences in rates of smoking abstinence at 26 or 52 weeks following a 12-week treatment with a nicotine patch, varenicline, or combination nicotine replacement therapy (nicotine patch + nicotine lozenge [C-NRT]), in adults trying to quit smoking.

Compared to those who continued smoking, those who stopped experienced a significant decline in the rate of brain volume loss.